Tord Labuda

Tord Labuda is a seasoned leader in the biopharma and life sciences sectors, currently serving as the Chief Executive Officer at Alzinova AB since October 2024, focusing on immunotherapies for Alzheimer’s disease. In addition to this role, Tord Labuda contributes pro bono to the Nordic Mentor Network for Entrepreneurship, aiding Nordic life science startups. As the Founder and CEO of TL Medvision AB since October 2023, Tord Labuda provides consultancy in biotech, MedTech, and pharmaceutical sectors. Tord Labuda holds a notable history at LEO Pharma, where leadership roles spanned from Vice President of Global Clinical Development to President and Japan Representative Director. Academic credentials include a PhD in Tumor Immunology from Lund University and an Executive Education degree in Management and Corporate Governance.